DocGo Inc. 8-K

What Happened

• On June 26, 2026, DocGo Inc.'s Board of Directors approved an extension of the company's existing share repurchase program. The program’s expiration date was extended from June 30, 2026 to December 31, 2026. No other changes were made to the program.
• Under the extended repurchase program, DocGo may buy up to $26 million of its common stock on a discretionary basis through open-market purchases, privately negotiated transactions, Rule 10b5-1 trading plans, accelerated share repurchase programs, or other permitted methods, subject to insider trading windows and the absence of material non-public information.

Key Details

• Board approval date: June 26, 2026.
• New expiration date: December 31, 2026 (previously June 30, 2026).
• Authorization: Up to $26.0 million in common stock repurchases (no increase to the authorized amount).
• Repurchases may be funded from cash and cash equivalents, future cash flow, or borrowings; timing and amount are discretionary and may be modified, suspended, or discontinued.

Why It Matters

• A share repurchase program gives the company flexibility to buy back shares, which can reduce outstanding share count and potentially support earnings per share and market price when executed.
• The extension signals management wants more time to use the previously authorized $26M but does not increase the buyback authorization; there is no guarantee any repurchases will occur.
• Investors should note repurchases depend on cash, market conditions, and regulatory constraints and could be paused or stopped at any time.